UK Health Security Agency, An Executive Agency of the Department of Health and Social Care
Official name: UK Health Security Agency, An Executive Agency of the Department of Health and Social Care (Trading as Manchester Medical Microbiology Partnership)
161 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Manchester Medical Microbiology Partnership, Clinical Sciences Building, Manchester Royal Infirmary, Oxford Road
Manchester M13 9WL , United Kingdom
Manchester M13 9WL , United Kingdom
Accreditation
Active
UKAS
10175
mft.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
10175
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (161)
| Standard Reference | Description | Category |
|---|---|---|
| Coronavirus OC43 | Coronavirus OC43 | Biocompatibility (ISO 10993) |
| Human Metapneumovirus | Human Metapneumovirus | Biocompatibility (ISO 10993) |
| Hepatitis A IgM | Hepatitis-A IgM | Biological / Microbiological |
| Antibiotic susceptibility testing (MIC) for Neisseria meningitidis measurement | Antibiotic susceptibility testing (MIC) for Neisseria meningitidis measurement | Clinical Microbiology |
| Antimicrobial susceptibility testing (AST) | Antimicrobial susceptibility testing (AST) | Clinical Microbiology |
| Culture and detection of microorganisms of clinical significance measurement | Culture and detection of microorganisms of clinical significance measurement | Clinical Microbiology |
| Detection and quantification of white blood cells, red blood cells, Differentiation of different organism types: Gram positive/negative/variable, branching organisms, yeasts | Detection and quantification of white blood cells, red blood cells, Differentiation of different organism types: Gram positive/negative/variable, branching organisms, yeasts | Clinical Microbiology |
| Detection of Acid Fast Bacilli | Detection of Acid Fast Bacilli | Clinical Microbiology |
| General isolation and characterisation of bacterial and fungal isolates of clinical significance from urinary specimens | General isolation and characterisation of bacterial and fungal isolates of clinical significance from urinary specimens | Clinical Microbiology |
| Identification of Microorganisms of clinical significance | Identification of microorganisms of clinical significance | Clinical Microbiology |
| Identification of Neisseria meningitidis | Identification of Neisseria meningitidis | Clinical Microbiology |
| Identification of microorganisms of clinical significance measurement | Identification of microorganisms of clinical significance measurement | Clinical Microbiology |
| Isolation and characterisation of carbapenemase producing | Isolation and characterisation of carbapenemase producing | Clinical Microbiology |
| Isolation and characterisation of microorganisms from respiratory specimens of clinical significance measurement | Isolation and characterisation of microorganisms from respiratory specimens of clinical significance measurement | Clinical Microbiology |
| Isolation and characterisation of microorganisms of Clinical significance | Isolation and characterisation of microorganisms of Clinical significance | Clinical Microbiology |
| Isolation and characterisation of microorganisms of clinical significance including MRSA | Isolation and characterisation of microorganisms of clinical significance including MRSA | Clinical Microbiology |
| Isolation and characterisation of mycobacteria | Isolation and characterisation of mycobacteria | Clinical Microbiology |
| Isolation and characterisation of mycobacteria measurement | Isolation and characterisation of mycobacteria measurement | Clinical Microbiology |
| Isolation and identification of fungi of clinical significance | Isolation and identification of fungi of clinical significance | Clinical Microbiology |
| Microbiological examination activities for the purpose of clinical diagnosis | Microbiological examination activities for the purpose of clinical diagnosis | Clinical Microbiology |
| Microbiology examination activities for the purpose of clinical diagnosis | Microbiology examination activities for the purpose of clinical diagnosis | Clinical Microbiology |
| Presence or absence of fungal elements | Presence or absence of fungal elements | Clinical Microbiology |
| Salmonella | Salmonella | Clinical Microbiology |
| Shigella species/Enteroinvasive | Shigella species/Enteroinvasive | Clinical Microbiology |
| MEASUREMENT | Measurement | Electrical |
| Campylobacter | Campylobacter | Food Safety Testing |
| Coronavirus 229E | Coronavirus 229E | Food Safety Testing |
| Coronavirus HKU1 | Coronavirus HKU1 | Food Safety Testing |
| Coronavirus NL63 | Coronavirus NL63 | Food Safety Testing |
| Enterobacteriaceae | Enterobacteriaceae | Food Safety Testing |
| Escherichia coli (EIEC) | Escherichia coli (EIEC) | Food Safety Testing |
| Giardia | Giardia | Food Safety Testing |
| Hepatitis B Core IgM | Hepatitis-B-core-IgM | Food Safety Testing |
| Hepatitis B e Antigen | Hepatitis B-e-Antigen | Food Safety Testing |
| Streptococcus pneumoniae | Streptococcus pneumoniae | Food Safety Testing |
| Detection of the Following: Acid and Neutral Mucins | Detection of the following: | Special Staining using in house | Histopathology / Cytology |
| Adenovirus | Adenovirus | Immunology / Serology |
| CMV IgG and avidity | CMV IgG and avidity | Immunology / Serology |
| Chlamydia pneumoniae | Chlamydia pneumoniae | Immunology / Serology |
| Cryptosporidium | Cryptosporidium | Immunology / Serology |
| Cytomegalovirus IgG & IgM | Cytomegalovirus IgG & IgM | Immunology / Serology |
| Detection of Cryptococcal antigen | Detection of cryptococcal antigen | Immunology / Serology |
| Detection of HIV 1 and 2 antibodies | Detection of HIV 1 and 2 antibodies | Immunology / Serology |
| HIV antigen & antibody | HIV antigen & antibody | Immunology / Serology |
| HSV IgG & IgM | HSV IgG & IgM | Immunology / Serology |
| Hepatitis A Total | Hepatitis A Total | Immunology / Serology |
| Hepatitis B Core ab (total) | Hepatitis B Core ab (total) | Immunology / Serology |
| Hepatitis B Core antibody (total) | Hepatitis B Core antibody (total) | Immunology / Serology |
| Hepatitis B Surface Antibody | Hepatitis B surface antibody | Immunology / Serology |
| Hepatitis B Surface Antigen | Hepatitis-B-surface-Antigen | Immunology / Serology |
| Hepatitis B e Antibody | Hepatitis B e antibody | Immunology / Serology |
| Hepatitis C Antibody | Hepatitis C Antibody | Immunology / Serology |
| Hepatitis C Virus antibody confirmation | Hepatitis C Virus antibody confirmation | Immunology / Serology |
| Hepatitis E Virus (HEV) IgM measurement | Hepatitis E Virus (HEV) IgM measurement | Immunology / Serology |
| Hepatitis delta antibody measurement | Hepatitis delta antibody measurement | Immunology / Serology |
| Herpes Simplex Virus 1 IgG | Herpes simplex Virus 1 IgG | Immunology / Serology |
| Herpes Simplex Virus 2 IgG | Herpes simplex Virus 2 IgG | Immunology / Serology |
| Influenza B | Influenza B | Immunology / Serology |
| Lyme IgG & IgM | Lyme IgG & IgM | Immunology / Serology |
| Measles IgG & IgM | Measles IgG & IgM | Immunology / Serology |
| Mumps IgG & IgM | Mumps IgG & IgM | Immunology / Serology |
| Parvovirus IgG & IgM | Parvovirus IgG & IgM | Immunology / Serology |
| Qualitative Detection of: HBc IgM | Qualitative detection of: | Roche Cobas Pro 801 Immunoassay | Immunology / Serology |
| Qualitative detection of the following: C1Q | Qualitative detection of the following: Cytomegalovirus (CMV) IgG Cytomegalovirus (CMV) IgM Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG Epstein Barr Virus (EBV) viral capsid antigen (VCA) IgM Epstein-Barr Virus Nuclear Antigen (EBNA) Toxoplasma IgG Toxoplamsa IgM Varicella Zoster IgG Measles IgG Mumps IgG | Immunology / Serology |
| Rubella IgG & IgM | Rubella IgG & IgM | Immunology / Serology |
| Serological determination of immune response to vaccine by measurement of IgG for the following: Haemophilus influenzae type b Tetanus Diphtheria | Serological determination of immune response to vaccine by measurement of IgG for the following: Haemophilus influenzae type b Tetanus Diphtheria | Immunology / Serology |
| Serological determination of immune responses to vaccine preventable disease | Serological determination of immune responses to vaccine preventable disease | Immunology / Serology |
| Serology examination activities for the purpose of clinical diagnosis | Serology examination activities for the purpose of clinical diagnosis | Immunology / Serology |
| Syphilis IgG | Syphilis IgG | Immunology / Serology |
| Toxoplasma IgG, IgM & avidity | Toxoplasma IgG, IgM & avidity | Immunology / Serology |
| Varicella Zoster IgG & IgM | Varicella Zoster IgG & IgM | Immunology / Serology |
| Virus (HTLV) antibody | Virus (HTLV) antibody | Immunology / Serology |
| Bordetella parapertussis (IS1001) | Bordetella parapertussis (IS1001) | Molecular Diagnostics / PCR |
| Bordetella pertussis (ptxP) | Bordetella pertussis (ptxP) | Molecular Diagnostics / PCR |
| Cepheid for detection of MTB complex, and 13 other | Cepheid for detection of MTB complex, and 13 other | Molecular Diagnostics / PCR |
| DNA | DNA | Molecular Diagnostics / PCR |
| Detection of CMV resistance | Detection of CMV resistance | Molecular Diagnostics / PCR |
| Detection of Chlamydia trachomatis RNA, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis DNA measurement | Detection of Chlamydia trachomatis RNA, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis DNA measurement | Molecular Diagnostics / PCR |
| Detection of Influenza A, B and RSV | Detection of Influenza A, B and RSV | Molecular Diagnostics / PCR |
| Detection of Norovirus GI and GII, Adenovirus 40/41, Astrovirus, Rotavirus, Sapovirus | Detection of Norovirus GI and GII, Adenovirus 40/41, Astrovirus, Rotavirus, Sapovirus | Molecular Diagnostics / PCR |
| Detection of SARS CoV-2 virus | Detection of SARS CoV-2 virus | Molecular Diagnostics / PCR |
| HAIN for detection of MTB complex, rifampicin and isoniazid resistance | HAIN for detection of MTB complex, rifampicin and isoniazid resistance | Molecular Diagnostics / PCR |
| HIV resistance, integrase, tropism measurement | HIV resistance, integrase, tropism measurement | Molecular Diagnostics / PCR |
| Hepatitis B DNA | Hepatitis B DNA | Molecular Diagnostics / PCR |
| Hepatitis C RNA | Hepatitis C RNA | Molecular Diagnostics / PCR |
| Herpes virus 6 & 7 DNA | Herpes virus 6 & 7 DNA | Molecular Diagnostics / PCR |
| Human Rhinovirus/Enterovirus | Human Rhinovirus/Enterovirus | Molecular Diagnostics / PCR |
| Meningococcal (incorporating ctrA gene and serogroup B) and pneumococcal DNA Meningococcal serogroups A, C, Y, W confirmatory assays measurement | Meningococcal (incorporating ctrA gene and serogroup B) and pneumococcal DNA Meningococcal serogroups A, C, Y, W confirmatory assays measurement | Molecular Diagnostics / PCR |
| Molecular Examination activities for the purpose of clinical diagnosis | Molecular examination activities for the purpose of clinical diagnosis | Molecular Diagnostics / PCR |
| Molecular detection of Carbapenemase Producing | Molecular detection of Carbapenemase Producing | Molecular Diagnostics / PCR |
| Molecular detection of mycobacteria | Molecular detection of mycobacteria | Molecular Diagnostics / PCR |
| Molecular examination activities for the purposes of clinical diagnosis | Molecular examination activities for the purposes of clinical diagnosis: Detection of Chlamydia trachomatis and Neisseria gonorrhoea | Molecular Diagnostics / PCR |
| Parainfluenza Virus 1 | VTM or UTM | Parainfluenza Virus 1 | Molecular Diagnostics / PCR |
| Parainfluenza Virus 2 | VTM or UTM | Parainfluenza Virus 2 | Molecular Diagnostics / PCR |
| Parainfluenza Virus 3 | VTM or UTM | Parainfluenza Virus 3 | Molecular Diagnostics / PCR |
| Parainfluenza Virus 4 | VTM or UTM | Parainfluenza Virus 4 | Molecular Diagnostics / PCR |
| Qualitative detection of Enterovirus and Parechovirus RNA | Qualitative detection of Enterovirus and Parechovirus RNA | Molecular Diagnostics / PCR |
| Qualitative detection of Herpes simplex 1 & 2 DNA | Qualitative detection of Herpes simplex 1 & 2 DNA | Molecular Diagnostics / PCR |
| Qualitative detection of Measles | Qualitative detection of Measles | Molecular Diagnostics / PCR |
| Qualitative detection of Mycoplasma pneumoniae DNA | Qualitative detection of Mycoplasma pneumoniae DNA | Molecular Diagnostics / PCR |
| Qualitative detection of Parvovirus B19 DNA | Qualitative detection of Parvovirus B19 DNA | Molecular Diagnostics / PCR |
| Qualitative detection of Pneumocystis jiroveci DNA measurement | Qualitative detection of Pneumocystis jiroveci DNA measurement | Molecular Diagnostics / PCR |
| Qualitative detection of Polyoma (BK and JC) DNA | Qualitative detection of Polyoma (BK and JC) DNA | Molecular Diagnostics / PCR |
| Qualitative detection of Toxoplasma gondii DNA | Qualitative detection of Toxoplasma gondii DNA | Molecular Diagnostics / PCR |
| Quantitative detection of Adenovirus DNA | Quantitative detection of Adenovirus DNA | Molecular Diagnostics / PCR |
| Quantitative detection of CMV | Quantitative detection of CMV | Molecular Diagnostics / PCR |
| Quantitative detection of EBV | Quantitative detection of EBV | Molecular Diagnostics / PCR |
| Quantitative viral load for: HIV RNA | Quantitative viral load for: HIV RNA | Molecular Diagnostics / PCR |
| RNA (COVID-19) specific gene sequences: E, N2 | RNA (COVID-19) specific gene sequences: SARS-CoV-2a (ORF1 gene) and SARS-CoV-2b (ORF8 gene) | Molecular Diagnostics / PCR |
| RNA (COVID-19), influenza A, influenza B and RSV | RNA (COVID-19), influenza A, influenza B and RSV | Molecular Diagnostics / PCR |
| Respiratory Syncytial Virus | Respiratory Syncytial Virus | Molecular Diagnostics / PCR |
| Respiratory Virus Panel | Respiratory virus panel | Molecular Diagnostics / PCR |
| Treponema pallidum DNA | Treponema pallidum-DNA | Molecular Diagnostics / PCR |
| Varicella zoster DNA | Varicella zoster DNA | Molecular Diagnostics / PCR |
| Clostridioides difficile measurement | Clostridioides difficile measurement | Other |
| Coronavirus (MERS-CoV) | Coronavirus (MERS-CoV) | Other |
| Detection and quantification of white blood cells, red blood cells, epithelial cells and bacteria | Detection and quantification of white blood cells, red blood cells, epithelial cells and bacteria | Other |
| Detection of Legionella and Streptococcus pneumoniae antigen | Detection of Legionella and Streptococcus pneumoniae antigen | Other |
| Detection of Middle East | Detection of Middle East | Other |
| Detection of antigen to Neisseria meningitidis | Detection of antigen to Neisseria meningitidis | Other |
| Determination of serum bactericidal antibody level for the following Neisseria meningitidis serogroups A, C, Y, W | Determination of serum bactericidal antibody level for the following Neisseria meningitidis serogroups A, C, Y, W | Other |
| Escherichia coli (STEC) Stx1 & | Escherichia coli (STEC) Stx1 & | Other |
| H1, H1-2009, and H3 | H1, H1-2009, and H3 | Other |
| Human T-Cell Lymphotropic | Human T-Cell Lymphotropic | Other |
| Identification/confirmation of faecal parasites | Identification/confirmation of faecal parasites | Other |
| IgG, IgM & EBNA IgG | IgG, IgM & EBNA IgG | Other |
| Influenza A, including subtypes | Influenza A, including subtypes | Other |
| Meningococcal reference unit | Meningococcal reference unit | Other |
| Microbiological examination activities for the purpose of clinical diagnosis Meningococcal reference unit | Microbiological examination activities for the purpose of clinical diagnosis Meningococcal reference unit | Other |
| Middle East Respiratory | Middle East Respiratory | Other |
| Mycobacterium species, and rifampicin resistance | Mycobacterium species, and rifampicin resistance | Other |
| Mycoplasma pneumoniae measurement | Mycoplasma pneumoniae measurement | Other |
| Papilloma virus, types16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 | Papilloma virus, types16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 | Other |
| Qualitative Detection of Aspergillus DNA | Qualitative Detection of Aspergillus DNA | Other |
| Qualitative Detection of Candida | Qualitative Detection of Candida | Other |
| Qualitative detection of Human | Qualitative detection of Human | Other |
| RNA | RNA | Other |
| Respiratory Syndrome | Respiratory Syndrome | Other |
| Sero-grouping and outer membrane typing of Neisseria meningitidis | Sero-grouping and outer membrane typing of Neisseria meningitidis | Other |
| Serotype 1 | Serotype 1 | Other |
| Serotype 14 | Serotype 14 | Other |
| Serotype 18C | Serotype 18C | Other |
| Serotype 19A | Serotype 19A | Other |
| Serotype 19F | Serotype 19F | Other |
| Serotype 23F measurement | Serotype 23F measurement | Other |
| Serotype 3 | Serotype 3 | Other |
| Serotype 4 | Serotype 4 | Other |
| Serotype 5 | Serotype 5 | Other |
| Serotype 6B | Serotype 6B | Other |
| Serotype 7F | Serotype 7F | Other |
| Serotype 9V | Serotype 9V | Other |
| Severe Acute Respiratory | Severe Acute Respiratory | Other |
| Shiga toxin producing | Shiga toxin producing | Other |
| Stx2, Yersinia | Stx2, Yersinia | Other |
| Syndrome Coronavirus (MERS- CoV) | Syndrome Coronavirus (MERS- CoV) | Other |
| Syndrome Coronavirus 2 (SARS-CoV-2) | Syndrome Coronavirus 2 (SARS-CoV-2) | Other |
| Syphilis confirmation RPR titre measurement | Syphilis confirmation RPR titre measurement | Other |
| Vaccine Evaluation Unit | Vaccine Evaluation Unit | Other |
| Vibrio species | Vibrio species | Other |
| Whole Genome Sequencing of SARS-CoV-2 | Whole Genome Sequencing of SARS-CoV-2 | Other |
| Entamoeba histolytica | Entamoeba histolytica | Sterility Testing |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.